Theravance Biopharma
TBPH
TBPH
81 hedge funds and large institutions have $525M invested in Theravance Biopharma in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.
Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
2.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
31
Reduced
23
Closed
12
Calls
$1.11M
Puts
$920K
Net Calls
+$191K
Net Calls Change
+$97K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Geode Capital Management
Boston,
Massachusetts
| $3.63K | +$288 | +15,340 | +9% |
|
77
JPMorgan Chase & Co
New York
| $2K | -$2.77K | -151 | -58% |
|
|
PI
78
Putnam Investments
Boston,
Massachusetts
| – | -$1.23M | -74,725 | Closed |
|
|
GAM
79
Gotham Asset Management
New York
| – | -$733K | -69,582 | Closed |
|
80
Millennium Management
New York
| – | -$1.03M | -62,978 | Closed |
|
81
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$820K | -50,000 | Closed |
|
|
HCM
82
Highbridge Capital Management
New York
| – | -$295K | -17,976 | Closed |
|
83
Citadel Advisors
Miami,
Florida
| – | -$222K | -13,537 | Closed |
|
84
Renaissance Technologies
New York
| – | -$178K | -10,880 | Closed |
|
85
BNP Paribas Financial Markets
Paris,
France
| – | -$102K | -6,202 | Closed |
|
|
TRCT
86
Tower Research Capital (TRC)
New York
| – | -$2K | -124 | Closed |
|
|
IA
87
IFP Advisors
Tampa,
Florida
| – | -$1K | -57 | Closed |
|
88
US Bancorp
Minneapolis,
Minnesota
| – | -$1K | -41 | Closed |
|